Molecular Mechanisms of Sanguinarine in Cancer Prevention and Treatment

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

Historically, natural plant-derived drugs received a great impact of consideration in the treatment of several human-associated disorders. Cancer is a devastating disease and the second most cause of mortality. Sanguinarine (SANG), a naturally isolated plant alkaloidal agent, possesses chemo-preventive effects. Several studies have revealed that SANG impedes tumor metastasis and development by disrupting a wide range of cell signaling pathways and its molecular targets, such as BCL-2, MAPKs, Akt, NF-κB, ROS, and microRNAs (miRNAs). However, its low chemical stability and poor oral bioavailability remain key issues in its use as a medicinal molecule. A novel method (e.g., liposomes, nanoparticles, and micelles) and alternative analogs provide an exciting approach to alleviate these problems and broaden its pharmacokinetic profile. Cancer-specific miRNA expression is synchronized by SANG, which has also been uncertain. In this critical study, we review the utilization of SANG mimics and nano-technologies to improve its support in cancer. We focus on recently disclosed studies on SANG anti-cancer properties.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:23

Enthalten in:

Anti-cancer agents in medicinal chemistry - 23(2023), 7 vom: 30., Seite 765-778

Sprache:

Englisch

Beteiligte Personen:

Ullah, Asmat [VerfasserIn]
Ullah, Najeeb [VerfasserIn]
Nawaz, Touseef [VerfasserIn]
Aziz, Tariq [VerfasserIn]

Links:

Volltext

Themen:

AV9VK043SS
Antineoplastic Agents
Benzophenanthridines
Cancer
Chemo-preventive effects
Isoquinolines
Journal Article
MicroRNAs
Molecular target
Nanoparticle
Natural agent
Review
Sanguinarine

Anmerkungen:

Date Completed 15.03.2023

Date Revised 25.04.2023

published: Print

Citation Status MEDLINE

doi:

10.2174/1871520622666220831124321

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM345628624